Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intra-host diversity of drug-resistant cytomegalovirus: A case report of cytomegalovirus infection after allogeneic hematopoietic cell transplantation.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy - 1 Oct 2022

Jung Ji-Yoon, Nho Dukhee, Cho Sung-Yeon, Lee Dong-Gun, Choi Su-Mi, Kim Hee-Je, Kim Myungshin, Oh Eun-Jee

Abstract excerpt

Cytomegalovirus (CMV) is a major infectious agent causing severe complications in allogeneic hematopoietic cell transplantation (HCT) recipients, thereby warranting the need for aggressive preemptive or targeted antiviral therapy. However, prolonged or repeated use of antiviral agents, such as ganciclovir (GCV), foscarnet (FOS), and cidofovir (CDV), can result in drug-resistant CMV infection, posing challenges to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Cytomegalovirus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytomegalovirus Infections

Share to Drug Resistance, Viral

Share to Foscarnet

Share to Ganciclovir

Share to Hematopoietic Stem Cell Transplantation

Share to Phosphotransferases (Alcohol Group Acceptor)

Source

Identifiers

PMID: 35810104
DOI: 10.1016/j.jiac.2022.05.020

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Intra-host diversity of drug-resistant cytomegalovirus: A case report of cytomegalovirus infection after allogeneic hematopoietic cell transplantation.PMID 35810104Read ↗

Drug-resistant cytomegalovirus: clinical implications of specific mutations.Semantic proximity Read ↗

Prevalence of cytomegalovirus antiviral drug resistance in transplant recipients.Semantic proximity Read ↗

The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.Semantic proximity Read ↗

Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing.Semantic proximity Read ↗

Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.Semantic proximity Read ↗

How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients.Semantic proximity Read ↗

The biology of cytomegalovirus drug resistance.Semantic proximity Read ↗

Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.Semantic proximity Read ↗

Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.Semantic proximity Read ↗

Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study.Semantic proximity Read ↗

Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing.Semantic proximity Read ↗

Leflunomide therapy for refractory cytomegalovirus infections in hematopoietic stem cell transplant recipients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.